Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United KingdomUpdates
SUB-TYPE: COMPANY-LED RECALL
Company Led Recall - Invita D3 800 IU Soft Capsules (28)
Consilient Health UK Ltd is recalling a specific batch due to limited units from the batch being distributed prior to batch release.
Limited number of units from the batch were distributed prior to batch release. There are no indications of any quality of safety concerns and this recall is precautionary due to the regulatory non-compliance.
This recall is being issued as a company-led medicines recall, as this product is only supplied to several pharmacies and the company has traceability of the onward distribution by their customers.
Remaining stock of the above batch should be quarantined and returned to the company directly.
MHRA drug alert date: 30 May 2022
MHRA drug alert link:
Pip code | Product description | Supplier | Affected Batches |
4039764 | INVITA D3 800 IU CAP (28) | CONSILIENT HEALTH UK LTD | 1389492 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
If you have any questions, then please contact your local Service Centre Customer Services team.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Phenobarbital 60mg Tablets
Bristol Laboratories Limited are recalling the below batch of product as a precautionary measure due to low dissolution test results reported during ongoing stability studies.
MHRA drug alert date: 13 June 2022
Pip code | Product Description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | PHENOBARBITAL 60MG TABLETS | BRISTOL LABORATORIES LIMITED | NW0001 |
Alliance do not stock the above product so we will not be accepting Customer returns on this recall.
Further Information
For more information, medical or supply enquiries, please contact notifications@bristol-labs.co.uk
Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice.
SUB-TYPE:
Supply Optimisation now on the myahportal
Over the past few months, we have heard that you want us to make the process of requesting additional items of product that is subject to Restricted Supply simpler for you, so we are delighted to announce the launch of a new innovative and customer friendly functionality on the Alliance Healthcare portal.
What change is taking place?
In addition to the online Prescription Validation Service, this new Supply Optimisation innovation will allow you to submit a product supply request for a product that is confirmed as being subject to Restricted Supply at the time of your standard order process rather than having to call customer services.
You can now place an order request 24/7 via the myahportal and track the progress of your request more easily and efficiently using the new supply optimisation tool.
This new functionality is available to all users, however administrators can remove access to users as required through the user admin functions.
What are the benefits for me?
- - Making it easier to do business with us
- - Simplifies the request for supply when an item is subject to Restricted Supply, and when you need more product than you would order in a typical month
- - Provides order progress updates so you can track your order via the myahportal
- - Provides you with your required stock quicker – due to this advanced technology
- - Modernises the process – no need to call or email us
- - Brings efficiencies to your business – another feature in our one stop shop offering provided by myahportal
When is this change taking place?
This new functionality is now live on the myahportal.
Here to Help
You can access the Supply Optimisation functions on the portal by:
- - Selecting the Supply Optimisation tile from your myahportal dashboard
- - Inputting the pip code and quantity you require and following the on-screen instructions
The status of all pending orders will be available in the order history section of the Supply Optimisation area.
To help assist you with this new service, please watch this short video on how to use the new portal functionality here.
If you experience any difficulties and require support, please contact the Customer Portal Team on 0330 100 0448 – option 8 or email CustomerPortal@alliance-healthcare.co.uk with ‘Supply Optimisation’ in the title of your email.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Water for Injections BP – 100ml vial x 25
Hameln pharma ltd are recalling batches of product additional to the batch recalled on 15 February 2022 (reference EL(22)A/06). This recall is conducted as a precautionary measure, as remaining vials may no longer be in line with the licensed product specification with respect to the parameters pH and conductivity.
MHRA drug alert date: 25 May 2022
Pip code | Product description | Supplier | Batch Numbers |
0769489 | WATER FOR INJ BP VIAL R/C 100ML (25) | HAMELN PHARMACEUTICALS LTD (MOV) | 019501 019502 019503 019504 019505 019506 920503 920506 920508 930503 930504 930505 931501 940501 940502 951504 952501 |
Further Information
For more information, medical or supply enquiries, please contact: drug.safety@hameln-pharma.co.uk
For stock control queries, please contact: customer.services@hameln-pharma.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification by the 26 August 2022, cannot be reimbursed by way of a credit
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Mefenamic Acid 500mg film coated, 30 tablets
Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated, 30 Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the tablet core being partially exposed.
MHRA drug alert link:
Pip code | Product Description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | MEFENAMIC ACID 500MG FILM COATED, 30 TABLETS | QUADRANT PHARMACEUTICALS LTD | 107082 |
Alliance do not stock the above product so we will not be accepting Customer returns on this recall.
Further Information
For more information, medical or supply enquiries, please contact joanne.fishwick@maxearn.co.uk or radoslaw.bandomir@maxearn.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE:
CARDENE order blackout period 17-18 May – LXO RWA
We are pleased to announce that, as of 19 May 2022, Alliance Healthcare UK will become the only wholesaler to supply CARDENE to all pharmacies, hospitals and dispensing doctors in England, Scotland and Wales. Northern Ireland is not included in this agreement.
CARDENE has been acquired by Laboratoire XO from Astellas. Following the morning deliveries on Tuesday 17 May Astellas was cease Direct to Pharmacy sales for these products and there will be a transition to a Reduced Wholesaler Model with Laboratoire XO. As a result of this transition there will be a blackout period for customer orders of these products between 17 – 18 May.
Final orders for these products will be your standard cut-off time on the evening of Monday 16 May for AM delivery on the Tuesday 17 May. Customers will be able to place orders with Alliance Healthcare for these products from Thursday AM 19 May for delivery from PM 19 May.
From 19 May purchases of these lines will continue to arrive as part of your usual Alliance Healthcare delivery service and, if purchased in isolation, they will not be subject to Alliance Healthcare’s low spend surcharge. To receive these products, you can simply order from Alliance Healthcare in your usual manner. These products will be available on a same day delivery service.
If you would like to discuss these changes in more detail, please do not hesitate to contact your Alliance Healthcare Account Manager.
Please see these communications from Alliance Healthcare and Laboratoire XO for more information:
Alliance Healthcare - CARDENE customer communication
SUB-TYPE:
Platinum Jubilee Service Information
To help keep our customers informed of changes to our service, we have published our Platinum Jubilee Bank Holiday opening hours.
For more information please click here
SUB-TYPE:
Alliance Healthcare marks £100k raised for Vitamin Angels UK
Alliance Healthcare marks £100,000 raised for Vitamin Angels UK to support its purpose in improving access to essential nutrition for mothers and children in the UK and around the world.
Yesterday, team members across Alliance Healthcare joined a virtual event called “Around the World” to celebrate the amazing £100,000 fundraising milestone. Marie Evans, Managing Director congratulated the teams who have completed cycle challenges, organised football matches and multiple fundraising events in aid of the charity.
Vitamin Angels UK provided an interactive virtual tour of the villages across the world where funds raised have helped create healthier futures. Over the last four years of the partnership, Alliance Healthcare and Vitamin Angels have reached the lives of over 468,600 children.
Sam Unsworth, CSR Champion for Alliance Healthcare closed the event and said: “We should be really proud of our fundraising efforts to support our charity partnership with Vitamin Angels. Today, was a moment to reflect on our achievement and hear more from the charity. This has really spurred us on to create even more impactful fundraising events. Together we will continue to make a meaningful difference for those that need it most.”
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Drug Caution In Use - Zovirax I.V. 500mg
GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is inside the sealed pack, and contains unapproved text.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
489633 | ZOVIRAX IV VIAL 500MG | GLAXOSMITHKLINE UK LTD | 9G4B TC8E-A 6V8W GN8S J69C B35J |
This is a caution in use only we are not accepting stock returns.
Further Information
If you have any questions, please contact GSK UK Ltd Medical Information Department on 0800 221 441 or email: ukmedinfo@gsk.com
SUB-TYPE:
Prince Charles praises pharmacy sector’s ‘dedication and professionalism’ during Covid-19 pandemic
Prince Charles has praised the “dedication and professionalism of pharmacy staff” at an event held in London to celebrate the work of community pharmacists during the Covid-19 pandemic.
His Royal Highness The Prince of Wales hosted a special event this week at St. James’s Palace State Apartments to celebrate Community Pharmacists.
200 community pharmacy members and other honoured guests, including Our Managing Director, Marie Evans had the privilege of attending.
Speaking about the event, Marie said: “Community pharmacy deserve this recognition, they continued to support UK patients at every moment of the pandemic – and beyond. Their unwavering dedication is something to be admired and celebrated. This has been a very fitting celebration for our remarkable community pharmacists and their teams.”
Read more about the event in the below link:
